Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 May;31(5):829–830. doi: 10.1128/aac.31.5.829

In vitro susceptibility of Citrobacter species to various antimicrobial agents.

G Samonis, D H Ho, G F Gooch, K V Rolston, G P Bodey
PMCID: PMC174846  PMID: 3606084

Abstract

The in vitro activities of 16 antimicrobial agents against 14 clinical isolates of Citrobacter diversus and 27 isolates of Citrobacter freundii were studied. C. freundii isolates were more resistant, being susceptible only to amikacin, netilmicin, gentamicin, imipenem, ciprofloxacin, and enoxacin. C. diversus isolates were susceptible to many more of the agents tested.

Full text

PDF
829

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson C. A., Walton F. E., Trenholme G. M. Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli. Antimicrob Agents Chemother. 1986 Jan;29(1):155–157. doi: 10.1128/aac.29.1.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bodey G. P., Buckley M., Sathe Y. S., Freireich E. J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966 Feb;64(2):328–340. doi: 10.7326/0003-4819-64-2-328. [DOI] [PubMed] [Google Scholar]
  3. Drelichman V., Band J. D. Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome. Arch Intern Med. 1985 Oct;145(10):1808–1810. [PubMed] [Google Scholar]
  4. Eliopoulos G. M., Moellering A. E., Reiszner E., Moellering R. C., Jr In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620. Antimicrob Agents Chemother. 1985 Oct;28(4):514–520. doi: 10.1128/aac.28.4.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fainstein V., Weaver S., Bodey G. P. Comparative in vitro study of SQ26,776. Antimicrob Agents Chemother. 1982 Feb;21(2):294–298. doi: 10.1128/aac.21.2.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fuchs P. C., Jones R. N., Barry A. L., Thornsberry C. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1985 May;27(5):679–682. doi: 10.1128/aac.27.5.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Garcia I., Bodey G. P., Fainstein V., Ho D. H., LeBlanc B. In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients. Antimicrob Agents Chemother. 1984 Sep;26(3):421–423. doi: 10.1128/aac.26.3.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Henry D., Skidmore A. G., Ngui-Yen J., Smith A., Smith J. A. In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents. Antimicrob Agents Chemother. 1985 Aug;28(2):259–264. doi: 10.1128/aac.28.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hodges G. R., Degener C. E., Barnes W. G. Clinical significance of citrobacter isolates. Am J Clin Pathol. 1978 Jul;70(1):37–40. doi: 10.1093/ajcp/70.1.37. [DOI] [PubMed] [Google Scholar]
  10. Hoy J. F., Rolston K. V., Ho D. H., Alvarez M., Thirolf P., Bodey G. P. In vitro activity of BRL 36650, a new semisynthetic penicillin. Antimicrob Agents Chemother. 1986 Jun;29(6):972–976. doi: 10.1128/aac.29.6.972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lipsky B. A., Hook E. W., 3rd, Smith A. A., Plorde J. J. Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis. 1980 Sep-Oct;2(5):746–760. doi: 10.1093/clinids/2.5.746. [DOI] [PubMed] [Google Scholar]
  12. Mandell W., Neu H. C. In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents. Antimicrob Agents Chemother. 1986 May;29(5):852–857. doi: 10.1128/aac.29.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Toda M., Arao N., Nohara C., Susaki K., Tachibana A. In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1985 Apr;27(4):565–569. doi: 10.1128/aac.27.4.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Vuye A., Pijck J. In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin. Antimicrob Agents Chemother. 1985 Apr;27(4):574–577. doi: 10.1128/aac.27.4.574. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES